Company: BIVIW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001520138-25-000144
Chunk: 18

Company: BIOVIE INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 18
---
 to the net loss for the periods presented.

The table below shows the potential shares of Common Stock, presented
based on amounts outstanding at each period end, which were excluded from the computation of diluted net loss per share attributable to
common stockholders because including them would have had an anti-dilutive effect:

    Schedule of dilutive securities were excluded from the computation of diluted loss per share 

    March 31, 2025  
    March 31, 2024 

    Number of Shares  
    Number of Shares 
  
    Stock Options 
     887,129  
     402,276 
  
    Warrants 
     9,600,564  
     1,932,029 
  
    Restricted Stock Units 
     109,039  
     53,992 
  
    Notes payable conversion option 
     -  
     71,633 
  
    Total 
     10,596,732  
     2,459,930 

Reverse stock split

The company effected a 1:10 reverse split of the issued
and outstanding shares of its Common Stock which was approved by the board of directors after the approval obtained from shareholders
at a special meeting on July 29, 2024 which became effective on Nasdaq on August 6, 2024, 5 trading days after the shareholders’
approval was obtained. All historical share and earnings per share amounts have been retroactively adjusted to reflect the split. 

     11 

Grant program

The Company records expenses related to the DOD Long
Covid Program as such expenses are incurred. The reimbursement of such expenses is recognized upon receipt of the reimbursement as a credit
against the respective expense account.

Recent Accounting Pronouncements

In November 2024, the Financial
Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Disaggregation of
Income Statement Expenses (“DISE”), which will require additional disclosure of the nature of expenses included in the income
statement in response to longstanding requests from investors for more information about an entity’s expenses. The new standard
requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as
well as disclosures about selling expenses. The new standard will be effective for public companies for fiscal years beginning after December
15, 2026, and interim periods within fiscal years beginning after December 15, 2027.